Takeda’s Dengue vaccine candidate reveals protection in children

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...

November 8, 2019 | Friday | News
FDA approves Sanofi’s Influenza Vaccine for older people

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone®&n...

November 5, 2019 | Tuesday | News
The Union reports efficacy of its TB Vaccine Candidate

International Union Against Tuberculosis and Lung Disease (The Union) headquartered in France, announces the Phase IIb T...

October 30, 2019 | Wednesday | News
NIH awards contracts to advance tuberculosis immunology research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarde...

September 27, 2019 | Friday | News
Alwaleed Philanthropies invests $5 M in global fight for vaccines

Alwaleed Philanthropies, chaired by HRH Prince Alwaleed Bin Talal Bin Abdulaziz AlSaud, the global philanthropic fo...

September 2, 2019 | Monday | News
Crozet partners with PHV to develop Nipah virus vaccine

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (P...

August 28, 2019 | Wednesday | News
Zuellig Pharma, NICVB, NIHE team up for accessibility of vaccines

The National Institute of Vaccines and Medical Biologicals (NICVB), the National Institute of Hygiene and Epidemiology (...

April 23, 2019 | Tuesday | News
The Govt. of EG, US Energy Companies & Sanaria collaborate for malaria vaccine

Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint ...

April 11, 2019 | Thursday | News
Serum Institute launches biggest immunisation awareness drive in India

Serum Institute of India (SII), vaccine manufacturer launched a nation-wide vaccination and immunisation campaign called...

February 22, 2019 | Friday | News
Vertex announces EC approval for ORKAMBI

Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of ...

January 24, 2019 | Thursday | News
Exelixis announces USFDA approval of CABOMETYX

Oncology focused biotechnology company, Exelixis has announced that USFDA has approved CABOMETYX tablets for patients wi...

January 16, 2019 | Wednesday | News
AstraZeneca’s Bevespi Aerosphere approved in the EU

AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...

January 3, 2019 | Thursday | News
FDA approves Sanofi & MSD’s VAXELIS™

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...

January 3, 2019 | Thursday | News
Philip Gutry appointed as Chief Business Officer by Kronos Bio

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...

November 28, 2018 | Wednesday | News
Esco, Nuvonis enter into MoU to support novel vaccines in Asia

Singapore - Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for ...

October 4, 2018 | Thursday | News
Enesi, Public Health England carry out R&D collaboration

Singapore - Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dosevac...

October 3, 2018 | Wednesday | News
GSK TB vaccine shows promise in phII study

Pharma giant GSK and Aeras reported that GSK’s candidate vaccine significantly reduced the incidence of pulmonary ...

September 30, 2018 | Sunday | News
Rotavirus vaccine options expand with WHO’s prequalification

PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL, ...

September 28, 2018 | Friday | News